Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness in Chronic Kidney Disease
Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness
Presentation: Looking At Cancer Differently: In Vivo Imaging
Join us at PIC 2024 as Evan Hoecht presents a new perspective on Cancer Research – “Looking At Cancer Differently: In Vivo Imaging”
Mark your calendars for Day 2 of the Preclinical Imaging Consortium, that’s happening at the University of Colorado Anschutz Medical Campus, Aurora on Thursday, May 30th, at 6:30 pm, immediately following Session #5 talks. Gain fresh insights and perspectives on understanding cancer from a whole new angle. Don’t miss out on this thought-provoking presentation that promises to redefine our understanding of cancer diagnostics and treatment strategies. Reserve your spot now for an event that’s sure to inspire and inform!
Presentation title: Looking At Cancer Differently: In Vivo Imaging
Date: Thursday, May 30th
Time: 6:30pm
Read more about Science!
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology View Paper Here
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways View Paper
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in BCMA CAR-NK Therapy
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB and its downstream factors
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders